January 31, 2014 / 3:05 PM / in 4 years

BRIEF-AbbVie says expects FDA to grant priority review to hepatitis c drugs

1 Min Read

Jan 31 (Reuters) - AbbVie Inc : * Says expects FDA to grant priority review to hepatitis c drugs * Says expects FDA to act on hepatitis c drug applications within 8 months or

sooner after receiving them

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below